John Curtin Distinguished Professor Chris Reid
- Vascular and metabolic disorders
Chris is a cardiovascular epidemiologist and clinical trialist on a mission to improve research quality and outcomes for people with cardiovascular disease.
Chris’s research has substantially advanced knowledge of factors associated with cardiovascular outcomes and preventions, with many of his findings incorporated into clinical guidelines for risk factor management.
Some of Chris’s recent work includes pioneering studies on the effect of low-dose aspirin in primary prevention in the healthy elderly. His research in this area earned him not one but three mentions in the Altmetric Top 100 list for 2018, placing his work among the world’s most mentioned scholarly research articles online for that year.
Chris is also Principal investigator at Curtin’s Centre for Research Excellence in Cardiovascular Outcomes Improvement – a centre focused on reducing the impact of cardiovascular disease through improved prevention; service management; and uptake of evidence-based strategies by individuals and communities.
Research interests – clinical trial and cohort studies; cardiovascular epidemiology; clinical outcome registries; epidemiological and pharmacoeconomic modelling.